Patents by Inventor Long V. Le

Long V. Le has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Microfluidic Assay and Bioproduction from Non-Mammalian Cells and Kits Therefor
    Publication number: 20240302378
    Abstract: Metabolic engineering has developed microbial cell factories as sustainable alternatives to chemical synthesis from petroleum feedstocks or harvesting of animals and plants, but current methods can be a costly and labor-intensive commitment. Methods are described herein for microfluidic methods of screening thousands of variant cells in order to reduce time and uncertainty to provide improved strains.
    Type: Application
    Filed: October 5, 2023
    Publication date: September 12, 2024
    Applicant: Bruker Cellular Analysis, Inc.
    Inventors: Or Gadish, Kellen C. Mobilia, Sara Tafoya, Eric K. Sackmann, Alexander J. Mastroianni, Peyton Shieh, Smriti Sridhar, Pierre Sphabmixay, Eva Y. Cheung, Grayson T. Wawrzyn, Long V. Le, Nathan J. Ver Heul, Bo Hu, Lily Chao, Ke-Chih Lin, Volker L.S. Kurz, Robert M. Onorato
  • Prevention and Treatment of Osteoarthritis by Inhibition of Insulin Growth Factor-1 Signaling
    Publication number: 20210369714
    Abstract: The present disclosure provides methods for treating or preventing osteoarthritis in a subject in need thereof. In certain aspects, the methods include administering an inhibitor of insulin growth factor-1 (IGF-1) signaling to a joint of the subject in an amount effective to treat or prevent osteoarthritis. In certain aspects, the osteoarthritis treated or prevented by the methods disclosed herein may to be post-traumatic osteoarthritis.
    Type: Application
    Filed: September 26, 2019
    Publication date: December 2, 2021
    Inventors: Daniel D. Bikle, Tejal Ashwin Desai, Long V. Le, Yongmei Wang